Skin penetration and tissue permeation after topical administration of diclofenac

References

• Brown MB, Martin GP, Jones SA, et al. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 2006;13:175-87
   PubMed Web of Science ®Google Scholar
• Stanos SP. Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs. J Multidiscip Healthc 2013;6:133-7
   PubMedGoogle Scholar
• Barkin R, Berckerman M, Blum S, et al. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging 2010;27:775-89
   Google Scholar
• Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum 2016;45(4 Suppl):S18-S21
   PubMed Web of Science ®Google Scholar
• Argoff C, Gloth FM. Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients. Ther Clin Risk Manag 2011;7:393-9
   PubMed Web of Science ®Google Scholar
• Chou R, McDonagh MS, Nakamoto E, et al. Analgesics for osteoarthritis: an update of the 2006 comparative effectiveness review. Comparative Effectiveness Review, Number 38. AHRQ Publication No. 11(12)-EHC076-EF. Rockville (MD): Agency for Healthcare Research and Quality (US). 2011
   Google Scholar
• Mason L, Moore R, Edwards J, et al. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Dis 2004;5:28
   PubMed Web of Science ®Google Scholar
• Lin J, Zhang W, Jones A, et al. Efficacy of topical NSAIDs in the treatment of osteoarthritis: a meta-analysis of randomized, controlled trials. BMJ 2004;329:324
   PubMed Web of Science ®Google Scholar
• National Institution for Health and Care Excellence (NICE). Osteoarthritis. Care and Management. Clinical Guidelines. 2014
   Google Scholar
• Bruyère O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum 2014;44:253-63
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:377-88
   PubMed Web of Science ®Google Scholar
• Underwood M, Ashby D, Cross P, et al. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ 2008;336:138-42
   PubMed Web of Science ®Google Scholar
• Carnes D, Anwer Y, Underwood M, et al. Influences on older people’s decision making regarding choice of topical or oral NSAIDs for knee pain: qualitative study. BMJ 2008;336:142
   PubMed Web of Science ®Google Scholar
• Nicholas Hall’s global OTC database D. 2015
   Google Scholar
• Derry S, Conaghan P, Da Silva JAP, et al. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2016;4:CD007400
   Web of Science ®Google Scholar
• Efe T, Sagnak E, Roessler PP, et al. Penetration of topical diclofenac sodium 4% spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial. Knee Surg Sports Traumatol Arthrosc 2014;22:345-50
   PubMed Web of Science ®Google Scholar
• Sofat N, Ejindu V, Kiely P. What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology 2011;50:2157-65
   PubMed Web of Science ®Google Scholar
• Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges. Bone 2016;85:81-90
   PubMed Web of Science ®Google Scholar
• Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013;21:16-21
   Web of Science ®Google Scholar
• Burian M, Tegeder I, Seegel M, et al. Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain. Clin Pharmacol Ther 2003;74:113-20
   PubMed Web of Science ®Google Scholar
• Malfait A-M, Schnitzer TJ. Towards a mechanism-based approach to pain management in osteoarthritis. Nat Rev Rheumatol 2013;9:654-64
   PubMed Web of Science ®Google Scholar
• Gan T. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin 2010;26:1715-31
   PubMed Web of Science ®Google Scholar
• Dong X-D, Svensson P, Cairns B. The analgesic action of topical diclofenac may be mediated through peripheral NMDA receptor antagonism. Pain 2009;147:36-45
   PubMed Web of Science ®Google Scholar
• Barron M, Rubin B. Managing osteoarthritic knee pain. J Am Osteopath Assoc 2007;107(Suppl 6):ES21-7
   Google Scholar
• Felson D. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 2004;42:1-9
   PubMed Web of Science ®Google Scholar
• O’Neill TW, Parkes MJ, Maricar N, et al. Synovial tissue volume: a treatment target in knee osteoarthritis. Ann Rheum Dis 2016;75:84-90
   PubMed Web of Science ®Google Scholar
• Witt KL, Vilensky JA. The anatomy of osteoarthritic joint pain. Clin Anat 2014;27:451-4
   PubMed Web of Science ®Google Scholar
• Creamer P, Hunt M, Dieppe P. Pain mechanisms in osteoarthritis of the knee: effect of intraarticular anesthetic. J Rheumatol 1996;23:1031-6
   PubMed Web of Science ®Google Scholar
• Giuliano F, Warner TD. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Br J Pharmacol 1999;126:1824-30
   PubMed Web of Science ®Google Scholar
• FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433-42
   PubMed Web of Science ®Google Scholar
• Huntjens DRH, Danhof M, Della Pasqua OE. Pharmacokinetic–pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors. Rheumatology 2005;44:846-59
   PubMed Web of Science ®Google Scholar
• Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg 2013;21:571-6
   PubMed Web of Science ®Google Scholar
• Altman R, Bosch B, Brune K, et al. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs 2015;75:859-77
   PubMed Web of Science ®Google Scholar
• Davies N, Anderson K. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 1997;33:184-213
   PubMed Web of Science ®Google Scholar
• Evans JMM, McMahon AD, McGilchrist MM, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: record linkage case control study. BMJ 1995;311:22-6
   PubMed Web of Science ®Google Scholar
• McPherson ML, Cimino NM. Topical NSAID formulations. Pain Med 2013;14:S35-S9
   PubMed Web of Science ®Google Scholar
• Weaver AL. Current and emerging treatments for mild/moderate acute ambulatory pain. Am J Ther 2008;15(Suppl 10):S12-S16
   PubMed Web of Science ®Google Scholar
• Henry D, Lim L, Garcia Rodriguez L, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-6
   PubMed Web of Science ®Google Scholar
• Odom DM, Mladsi DM, Saag KG, et al. Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews. Clin Ther 2014;36:906-17
   PubMed Web of Science ®Google Scholar
• Balmaceda CM. Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis. BMC Musculoskelet Dis 2014;15:27
   PubMed Web of Science ®Google Scholar
• Zacher J, Altman R, Bellamy N, et al. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin 2008;24:925-50
   PubMed Web of Science ®Google Scholar
• Heyneman C, Lawless-Liday C, Wall G. Oral versus topical NSAIDs in rheumatic diseases. A comparison. Drugs 2000;60:555-74
   PubMed Web of Science ®Google Scholar
• Moore R, Tramer M, Carroll D, et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998;316:333-8
   PubMed Web of Science ®Google Scholar
• Taylor RS, Fotopoulos G, Maibach H. Safety profile of topical diclofenac: a metaanalysis of blinded, randomized, controlled trials in musculoskeletal conditions. Curr Med Res Opin 2011;27:605-22
   PubMed Web of Science ®Google Scholar
• Barkin RL. Topical nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and therapeutic outcome. Am J Ther 2015;22:388-407
   PubMed Web of Science ®Google Scholar
• Chlud K, Wagener H. Percutaneous non-steroidal anti-inflammatory drug (NSAID) therapy with particular reference to pharmacokinetic factors. EULAR Bull 1987;2:40-3
   Google Scholar
• Massey T, Derry S, Moore R, et al. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev 2010;6:CD007402
   Web of Science ®Google Scholar
• Barry B. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharmaceut Sci 2001;14:101-14
   PubMed Web of Science ®Google Scholar
• Dreiser RL. Topical antirheumatic drug therapy: current practice and future trends. Eur J Rheumatol Inflamm 1994;14:3-8
   PubMedGoogle Scholar
• Rainsford K, Kean W, Ehrlich G. Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine. Curr Med Res Opin 2008;24:2967-92
   PubMed Web of Science ®Google Scholar
• Clijsen R, Baeyens JP, Barel AO, et al. In vivo determination of the diclofenac skin reservoir: comparison between passive, occlusive, and iontophoretic application. Drug Des Dev Ther 2015;9:835-40
   PubMed Web of Science ®Google Scholar
• Roberts MS, Cross SE, Anissimov YG. The skin reservoir for topically applied solutes. In: Bronaugh RL, Maibach H, eds. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methods. CRC Press, 2005:213-34
   Google Scholar
• Roberts MS, Cross SE. A physiological pharmacokinetic model for solute disposition in tissues below a topical application site. Pharm Res 1999;16:1392-8
   PubMed Web of Science ®Google Scholar
• Riess W, Schmid K, Bott L, et al. [The percutaneous absorption of diclofenac]. Arzneim-Forsch/Drug Res 1986;36:1092-6
   PubMed Web of Science ®Google Scholar
• Flynn G, Yalkowsky S, Roseman T. Mass transport phenomena and models. J Pharm Sci 1974;63:479-510
   PubMed Web of Science ®Google Scholar
• Singh P, Roberts MS. Skin permeability and local tissue concentrations of non-steroidal anti-inflammatory drugs after topical application. J Pharm Exp Ther 1994;268:144-51
   PubMed Web of Science ®Google Scholar
• Roberts MS, Cross SE, Anissimov YG. Factors affecting the formation of a skin reservoir for topically applied solutes. Skin Pharmacol Physiol 2004;17:3-16
   PubMed Web of Science ®Google Scholar
• Jepps OG, Dancik Y, Anissimov YG, et al. Modeling the human skin barrier – towards a better understanding of dermal absorption. Adv Drug Deliv Rev 2013;65:152-68
   PubMed Web of Science ®Google Scholar
• Lademann J, Knorr F, Richter H, et al. Hair follicles – an efficient storage and penetration pathway for topically applied substances. Skin Pharmacol Physiol 2008;21:150-5
   PubMed Web of Science ®Google Scholar
• Scheuplein RJ. Mechanism of percutaneous adsorption: I. Routes of penetration and the influence of solubility. J Invest Dermatol 1965;45:334-46
   PubMed Web of Science ®Google Scholar
• Gondolph-Zink B, Gronwald U. Active substance concentration in articular and periarticular tissues of the knee joint after cutaneous application of diclofenac-diethylammonium emulgel. Aktuelle Rheumatologie 1996;21:298-304
   Web of Science ®Google Scholar
• Radermacher J, Jentsch D, Scholl MA, et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmac 1991;31:537-41
   PubMed Web of Science ®Google Scholar
• Brune K. Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability. Curr Med Res Opin 2007;23:2985-95
   PubMed Web of Science ®Google Scholar
• Lee CM, Maibach H. Deep percutaneous penetration into muscles and joints. J Pharm Sci 2006;95:1405-13
   PubMed Web of Science ®Google Scholar
• Herkenne C, Naik A, Kalia YN, et al. Ibuprofen transport into and through skin from topical formulations: in vitro-in vivo comparison. J Invest Dermatol 2007;127:135-42
   PubMed Web of Science ®Google Scholar
• Magnusson BM, Anissimov YG, Cross SE, et al. Molecular size as the main determinant of solute maximum flux across the skin. J Invest Dermatol 2004;122:993-9
   PubMed Web of Science ®Google Scholar
• Fini A, Laus M, Orienti I, et al. Dissolution and partition thermodynamic functions of some nonsteroidal anti-inflammatory drugs. J Pharm Sci 1986;75:23-5
   PubMed Web of Science ®Google Scholar
• Hadgraft J, Somers G. Percutaneous absorption. J Pharm Pharmacol 1956;8:625-34
   PubMed Web of Science ®Google Scholar
• Sengupta C, Afeche P, Meyer-Brunot H, et al. Diclofenac sodium. In: Rainsford K, ed. Anti-Inflammatory and Anti-Rheumatic Drugs, Volume II: Newer Anti-Inflammatory Drugs. Boca Raton, FL: CRC Press, 1985:49-63
   Google Scholar
• Raza K, Kumar M, Kumar P, et al. Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems. Biomed Res Int 2014;2014:406731
   PubMed Web of Science ®Google Scholar
• Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery Int J Pharm 1999;184:1-6
   PubMed Web of Science ®Google Scholar
• Folzer E, Gonzalez D, Singh R, et al. Comparison of skin permeability for three diclofenac topical formulations: an in vitro study. Pharmazie 2014;69:27-31
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2012;64(Suppl):128-37
   Web of Science ®Google Scholar
• Hasler-Nguyen N, Fotopoulos G. Effect of rubbing on the in vitro skin permeation of diclofenac-diethylamine 1.16% gel. BMC Res Notes 2012;5:321
   PubMedGoogle Scholar
• Reiter S. Topical non-steroidal anti-inflammatory drugs. Bundesgesundheitsbl – Gesundheitforsch – Gesundheitsschutz 2000;12:950-9
   Google Scholar
• Zhai H, Maibach H. Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Appl Skin Physiol 2001;14:1-10
   PubMedGoogle Scholar
• Hewitt P, Poblete N, Wester R, et al. In vitro cutaneous disposition of a topical diclofenac lotion in human skin: effect of a multi-dose regimen. Pharm Res 1998;15:988-92
   PubMed Web of Science ®Google Scholar
• Patel P, Schmieder S, Krishnamurthy K. Research techniques made simple: drug delivery techniques, part 2: commonly used techniques to assess topical drug bioavailability. J Invest Dermatol 2016;136:e43-9
   PubMed Web of Science ®Google Scholar
• Bolzinger M, Briançon S, Pelletier J, et al. Penetration of drugs through skin, a complex rate-controlling membrane. Curr Opin Colloid Interface Sci 2012;17:156-65
   Web of Science ®Google Scholar
• Herkenne C, Alberti I, Naik A, et al. In vivo methods for the assessment of topical drug bioavailability. Pharm Res 2008;25:87
   PubMed Web of Science ®Google Scholar
• Cordero JA, Alarcon L, Escribano E. A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. Pharm Sci 1997;86:503-8
   PubMed Web of Science ®Google Scholar
• Goh C, Lane M. Formulation of diclofenac for dermal delivery. Int J Pharmaceut 2014;473:607-16
   PubMed Web of Science ®Google Scholar
• Brunner M, Davies D, Martin W, et al. A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects BJCP 2011;71:852-9
   Google Scholar
• Nivsarkar M, Maroo SH, Patel KR, et al. Evaluation of skin penetration of diclofenac from a novel topical non aqueous solution: a comparative bioavailability study. J Clin Diagnostic Res 2015;9:FC11-13
   PubMedGoogle Scholar
• Stahl J, Wohlert M, Kietzmann M. The effect of formulation vehicles on the in vitro percutaneous permeation of ibuprofen. BMC Pharmacol 2011;11:12
   PubMedGoogle Scholar
• Roth SH. The importance of differentiating between topical NSAID. Postgrad Med 2011;123:241-52
   Web of Science ®Google Scholar
• Akomeah F, Nazir T, Martin GP, et al. Effect of heat on the percutaneous absorption and skin retention of three model penetrants. Eur J Pharm Sci 2004;21:337-45
   PubMed Web of Science ®Google Scholar
• Dehghanyar P, Mayer BX, Namiranian K, et al. Topical skin penetration of diclofenac after single- and multiple-dose application. Int J Clin Pharmacol Ther 2004;42:353-9
   PubMed Web of Science ®Google Scholar
• Müller M, Rastelli C, Ferri P, et al. Transdermal penetration of diclofenac after multiple epicutaneous administration. J Rheumatol 1998;25:1833-6
   PubMed Web of Science ®Google Scholar
• Brunner M, Dehghanyar P, Seigfried B, et al. Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation. Br J Clin Pharmacol 2005;60:573-7
   PubMed Web of Science ®Google Scholar
• Stanos SP. Topical agents for the management of musculoskeletal pain. J Pain Symptom Manage 2007;33:342-55
   PubMed Web of Science ®Google Scholar
• Ternullo S, de Weerd L, Flaten G, et al. The isolated perfused human skin flap model: a missing link in skin penetration studies? Eur J Pharm Sci 2017;96:334-41
   PubMed Web of Science ®Google Scholar
• Flaten G, Palac Z, Engesland A, et al. In vitro skin models as a tool in optimization of drug formulation. Eur J Pharm Sci 2015;75:10-24
   PubMed Web of Science ®Google Scholar
• Raney S, Franz T, Lehman P, et al. Pharmacokinetics-based approaches for bioequivalence evaluation of topical dermatological drug products. Clin Pharmacokinet 2015;54:1095-106
   PubMed Web of Science ®Google Scholar
• Chik Z, Tucker AT, Shiel JI, et al. Comparative pharmacokinetic assessments of topical drugs: evaluation by dermatopharmacokinetics, microdialysis, and systemic measurement. J Invest Dermatol 2010;130:2828-30
   PubMed Web of Science ®Google Scholar
• Day RO, McLachlan AJ, Graham GG, et al. Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 1999;36:191-210
   PubMed Web of Science ®Google Scholar
• Dutta SK, Basu SK, Sen KK. Binding of diclofenac sodium with bovine serum albumin at different temperatures, pH and ionic strengths. Indian J Exp Biol 2006;44:123-127
   PubMedGoogle Scholar
• Elmquist WF, Chan KK, Sawchuk RJ. Transsynovial drug distribution: synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs. Pharm Res 1994;11:1689-97
   PubMed Web of Science ®Google Scholar
• Liauw H, Walter S, Lee L, et al. Effects of diclofenac on synovial eicosanoid product formation in arthritic patients. J Clin Pharmacol 1985;25:455-74
   Web of Science ®Google Scholar
• Sioufi A, Pommier F, Boschet F, et al. Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel. Biopharm Drug Dispos 1994;15:441-9
   PubMed Web of Science ®Google Scholar
• Cordero J, Camacho M, Obach R, et al. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharm Biopharm 2001;51:135-42
   PubMed Web of Science ®Google Scholar
• Anissimov Y, Roberts M. Mathematical models for topical and transdermal drug products. In: Shah VP, Maibach HI, Jenner J, eds. Topical Drug Bioavailability, Bioequivalence, and Penetration. New York, USA: Springer, 2014:249-98
   Google Scholar
• Chen L, Han L, Saib O, et al. In silico prediction of percutaneous absorption and disposition kinetics of chemicals. Pharm Res 2015;32:1779-93
   PubMed Web of Science ®Google Scholar
• Gallelli L, Galasso O, Falcone D, et al. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial. Osteoarthritis Cartilage 2013;21:1400-8
   PubMed Web of Science ®Google Scholar
• Gallelli L, Galasso O, Urzino A, et al. Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis. Clin Drug Invest 2012;32:827-33
   Web of Science ®Google Scholar
• Wible JH, Barrett T, Devarakonda K, et al. Biodistribution of diclofenac following repeated topical applications of two diclofenac sodium formulations to minipigs. Biopharm Drug Dispos 2014;35:87-96
   PubMed Web of Science ®Google Scholar
• Escribano E, Calpena AC, Queralt J, et al. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci 2003;19:203-10
   PubMed Web of Science ®Google Scholar
• Benson MD, Aldo-Benso M, Brandt KD. Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis. Semin Arthritis Rheum 1985;15(12 Suppl):65-7
   PubMed Web of Science ®Google Scholar
• Patrignani P, Panara MR, Greco A, et al. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Therapeut 1994;271:1705-12
   PubMed Web of Science ®Google Scholar
• Chlud K, Wagener H. Percutaneous therapy with non-steroidal anti-inflammatory drugs. Pharmacokinetic criteria of effectiveness. Fortschr Med 1991;109:59-60
   PubMedGoogle Scholar
• Martel-Pelletier J, Cloutier J-M, Pelletier J-P. Effects of aceclofenac and diclofenac on synovial inflammatory factors in human osteoarthritis. Clin Drug Invest 1997;14:226-32
   Web of Science ®Google Scholar
• Kato M, Nishida S, Kitasato H, et al. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharmacy Pharmacol 2001;53:1679-85
   PubMed Web of Science ®Google Scholar
• Riendeau D, Percival MD, Brideau C, et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharm Exp Ther 2001;296:558-66
   PubMed Web of Science ®Google Scholar
• Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 1999;96:7563-8
   PubMed Web of Science ®Google Scholar
• Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:413-21
   PubMed Web of Science ®Google Scholar
• Pairet M, van Ryn J, Schierok H, et al. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4’-isomer. Inflammation Res 1998;47:270-6
   PubMed Web of Science ®Google Scholar
• Liauw HL, Ku E, Brandt KD, et al. Effects of Voltaren on arachidonic acid metabolism in arthritis patients. Agents Actions Suppl 1985;17:195-9
   PubMedGoogle Scholar
• Chan KK, Vyas KH, Brandt KD. In vitro protein binding of diclofenac sodium in plasma and synovial fluid. J Pharm Sci 1987;76:105-8
   PubMed Web of Science ®Google Scholar
• van Erk M, Wopereis S, Rubingh C, et al. Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. BMC Med Genomics 2010;3:5
   PubMed Web of Science ®Google Scholar
• Haseeb A, Haqqi TM. Immunopathogenesis of osteoarthritis. Clin Immunol 2013;146:185-96
   PubMed Web of Science ®Google Scholar
• Inoue H, Takamori M, Shimoyama Y, et al. Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts. Br J Pharmacol 2002;136:287-95
   PubMed Web of Science ®Google Scholar
• Fowler PD, Dawes PT, John VA, et al. Plasma and synovial fluid concentrations of diclofenac sodium and its hyroxylated metabolites during once-daily administration of a 100mg slow release formulation. Eur J Clin Pharmacol 1986;31:469-72
   PubMed Web of Science ®Google Scholar
• Gierse JK, Koboldt CM, Walker MC, et al. Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J 1999;339(Pt 3):607-14
   PubMed Web of Science ®Google Scholar
• Muller PY, Milton MN. The determination and interpretation of the therapeutic index in drug development. Nat Rev Drug Discovery 2012;11:751-61
   PubMed Web of Science ®Google Scholar